Skip to content
GLP-1 Scorecard
Menu
Site position #98

KERNX Health

Published by GLP-1 ScorecardUpdated

A physician-led compounded GLP-1 program that names its prescribing clinicians and gates every charge behind a provider's approval, but keeps its dispensing pharmacy unnamed and runs no routine lab program.

Visit KERNX HealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$129/mo (compounded, plus a one-time consultation fee)
Tirzepatide
$229/mo (compounded, plus a one-time consultation fee)
Coverage
All 50 states
Brand-name
Not confirmed

Weigh KERNX Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value74/100
Dose & formulation68/100
Clinical oversight82/100
Labs & monitoring55/100
Fulfillment68/100
Contract terms86/100

Strengths

  • Prescribing clinicians are listed by name and credential rather than described as an anonymous "licensed provider network"
  • A provider approves treatment before any charge is processed, and the site states plainly when it is not the right fit
  • Monthly provider check-ins and a care team reachable seven days a week are included in the plan rather than sold as an upgrade
  • The dose ladder is published for both molecules, so a dose escalation has a known price attached before it happens

What to consider

  • The dispensing pharmacy is disclosed only in post-purchase paperwork, so no 503A or 503B status can be checked before you commit
  • Lab work is not part of the program: it is recommended case by case, billed separately, and may be sent to your own provider
  • Explicitly no health coaching or behavioral support — clinical oversight only
  • Injectable compounded medication only, with no oral route and no FDA-approved brand pathway
  • Cash-pay only, so nothing routes through insurance and no claim can be submitted for you

Bottom line — Grade C

Best for: Patients who care more about who is overseeing the prescription than about shaving the last dollar off the monthly price.

Site position #98 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest KERNX Health — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect KERNX Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on KERNX Health's site. Not medical advice; see our disclosure.

← Back to the scorecard